Cone-rod synaptic disorder, congenital nonprogressive
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness.
|
16960802 |
2006 |
Cone-rod synaptic disorder, congenital nonprogressive
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cone-rod synaptic disorder, congenital nonprogressive
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Cone-rod synaptic disorder, congenital nonprogressive
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Cone-rod synaptic disorder, congenital nonprogressive
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Night blindness, congenital stationary
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
This report significantly expands on the phenotype associated with calcium binding protein 4 mutations, which has so far been limited to congenital stationary night blindness, and further demonstrates how molecular data often blur the boundaries between what are believed to be clinically distinct retinal disorders.
|
20157620 |
2010 |
Night blindness, congenital stationary
|
0.620 |
GermlineCausalMutation
|
disease |
ORPHANET |
Here, we report for the first time that mutations in CABP4 lead to autosomal recessive CSNB.
|
16960802 |
2006 |
Night blindness, congenital stationary
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Here, we report for the first time that mutations in CABP4 lead to autosomal recessive CSNB.
|
16960802 |
2006 |
Night blindness, congenital stationary
|
0.620 |
Biomarker
|
disease |
HPO |
|
|
|
Night blindness, congenital stationary
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Exome sequencing identified a novel missense mutation c.464G>A (p.G155D) in Ca2+-binding protein 4 (CABP4) in a Chinese pedigree with autosomal dominant nocturnal frontal lobe epilepsy.
|
29108277 |
2017 |
Disorder of eye
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Disorder of eye
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Nyctalopia
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
We also functionally characterized two CaBP4 mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases.
|
22936811 |
2012 |
Nyctalopia
|
0.120 |
GeneticVariation
|
disease |
LHGDN |
Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness.
|
16960802 |
2006 |
Nyctalopia
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness.
|
16960802 |
2006 |
Nyctalopia
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Achromatopsia
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy.
|
30718709 |
2019 |
Cone-Rod Dystrophies
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy.
|
30718709 |
2019 |
Mean Corpuscular Volume (result)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Corpuscular Hemoglobin Concentration Mean
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Strabismus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Photophobia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Reduced visual acuity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|